Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HM30181A |
Trade Name | |
Synonyms | HM30181AK|Encequidar|HM-30181A |
Drug Descriptions |
HM30181A (Encequidar) inhibits the ABC transporter protein P-glycoprotein, which may reduce cellular efflux of chemotherapeutic agents (PMID: 25038758). |
DrugClasses | |
CAS Registry Number | 849675-66-7 |
NCIT ID | C11199 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Dostarlimab-gxly + HM30181A + Paclitaxel | Carboplatin Dostarlimab-gxly HM30181A Paclitaxel | 0 | 1 |
Carboplatin + Dostarlimab-gxly + HM30181A + Paclitaxel + Trastuzumab | Carboplatin Dostarlimab-gxly HM30181A Paclitaxel Trastuzumab | 0 | 1 |
HM30181A | HM30181A | 0 | 0 |
HM30181A + Topotecan | HM30181A Topotecan | 0 | 1 |